Contact UsBiological Products
> Biopharmaceutical Industry Insight & News > Biological Products
| Product | Leukokine? | Company | CJ HealthCare corp |
|---|---|---|---|
| Classification | Recombinant DNA product | Active Ingredient | Filgrastim (Recombinant human methionyl granulocyte colony-stimulating factor: r-metHuG-CSF) 150㎍/0.6mL, 300㎍/1.2mL |
| Reference Product | Approval Date | 1998 | |
| Indication | ⓐ Acceleration of an increase in the number of neutrophils following bone marrow transplantation ⓑ Neutropenia caused by cancer chemotherapy: malignant lymphoma, lung cancer, ovarian cancer, testicular cancer, neuroblastoma and acute leukemia |
||
| Description |
Leukokine? has the same efficacy and safety with those of the control on neutropenia
- For the neutropenia induced by chemotherapy in advanced cancer patients - For the neutropenia induced by chemotherapy in acute leukemia patients |
||
Korea Biomedicine Industry Association(KoBIA)
Address: 12, Teheran-ro 78-gil, Gangnam-gu, Seoul, Republic of Korea Tel: +82-2-725-8438 E-mail: info@kobia.kr
Address: 12, Teheran-ro 78-gil, Gangnam-gu, Seoul, Republic of Korea Tel: +82-2-725-8438 E-mail: info@kobia.kr
COPYRIGHT BY KoBIA. ALL RIGHTS RESERVED.